Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Show other versions (1)

Abstract Because there is no effective treatment for late‐stage prostate cancer (PCa) at this moment, identifying novel targets for therapy of advanced PCa is urgently needed. A new network‐based systems biology approach, XDeath, is developed to detect crosstalk of signaling pathways associated with...

Full description

Bibliographic Details
Main Authors: Zhuangzhuang Zhang, Lijun Cheng, Qiongsi Zhang, Yifan Kong, Daheng He, Kunyu Li, Matthew Rea, Jianling Wang, Ruixin Wang, Jinghui Liu, Zhiguo Li, Chongli Yuan, Enze Liu, Yvonne N. Fondufe‐Mittendorf, Lang Li, Tao Han, Chi Wang, Xiaoqi Liu
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Advanced Science
Subjects:
autophagy
cell death
crosstalk
DNMT3a
PCa
phosphorylation
Online Access:https://doi.org/10.1002/advs.202101458

Similar Items

Similar Items